Author: Tesfamariam Belay
Publisher: Adis International
ISSN: 1175-3277
Source: American Journal of Cardiovascular Drugs, Vol.6, Iss.2, 2006-01, pp. : 115-120
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Pleiotropic Effects of HMG-CoA Reductase Inhibitors: Their Role in Osteoporosis and Dementia
By Waldman A.
Drugs, Vol. 63, Iss. 2, 2003-01 ,pp. :
Effects of HMG-CoA Reductase Inhibitors on Coagulation and Fibrinolysis Processes
By Krysiak R. Okopien´ B. Herman Z.S.
Drugs, Vol. 63, Iss. 17, 2003-01 ,pp. :
HMG-CoA Reductase Inhibitors in the Prevention of Stroke
Drugs, Vol. 59, Iss. 1, 2000-01 ,pp. :
Comparative Tolerability of the HMG-CoA Reductase Inhibitors
By Farmer J.A. Torre-Amione G.
Drug Safety, Vol. 23, Iss. 3, 2000-09 ,pp. :